How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Agriculture · Forecast 2027–2033
RNA Interference-based Biopesticides Market
- By Target Pest Type: Insect Pests, Fungal Pathogens, Nematodes, Weeds
- By Application Method: Foliar Spray, Soil Treatment, Seed Treatment, Trunk Injection
- By Formulation Type: Liquid Formulations, Dry Powder Formulations, Encapsulated Formulations, Granular Formulations
- By Crop Type: Row Crops, Horticultural Crops, Turf and Ornamentals, Cereals and Grains
- By Mode of Delivery: Topical Application, Root Absorption, Systemic Delivery
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Insect Pests leads By Target Pest Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 14 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 289 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.175 →
- 12 Company Profiles 14 players: SWOT & benchmarking p.183 →
Full report · locked preview
Everything inside the RNA Interference-based Biopesticides Market report
A complete, evidence-based study - 12 chapters and 121 sections covering market size, segmentation across 5 axes, regional analysis and 14 company profiles, forecast to 2033.
Segmentation covered
Target Pest Type 4
Application Method 4
Formulation Type 4
Crop Type 4
Mode of Delivery 3
Companies profiled
Bayer CropScience
Syngenta AG
Corteva Agriscience
Mitsui Chemicals Agro Inc.
GreenLight Biosciences
RNAissance Ag
AgroSpheres Inc.
Vestaron Corporation
Noble Research Institute
Certis USA LLC
Valent BioSciences LLC
Andermatt Biocontrol AG
+2 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
14 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Bayer CropScience
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Syngenta AG
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Corteva Agriscience
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Mitsui Chemicals Agro Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →GreenLight Biosciences
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →RNAissance Ag
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →AgroSpheres Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Vestaron Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Noble Research Institute
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Certis USA LLC
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Valent BioSciences LLC
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Andermatt Biocontrol AG
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.220 →FMC Corporation
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Bioceres Crop Solutions
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$2,703M by 2033 · 4.0% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Insect Pests59.7
- Fungal Pathogens15.9
- Nematodes6.5
- Weeds17.9
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$651.0M → $905.6M · 4.2%
Europe$453.8M → $682.3M · 5.2%
Asia Pacific$414.3M → $588.2M · 4.5%
Latin America$256.5M → $326.7M · 3.1%
Middle East and Africa$197.3M → $264.1M · 3.7%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →3.972026
3.972027
3.982028
4.012029
4.022030
4.042031
4.042032
4.052033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Bayer CropScience27.1
- Syngenta AG10.2
- Corteva Agriscience7.0
- Mitsui Chemicals Agro Inc.5.1
- GreenLight Biosciences13.6
- RNAissance Ag9.0
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Target Pest Type25.5%
Application Method20.3%
Formulation Type20.3%
Crop Type14.2%
Mode of Delivery19.7%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America32.7
- Europe24.7
- Asia Pacific21.3
- Latin America11.8
- Middle East and Africa9.5
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Bayer CropScience | 97 | 91 | 75 | 85 | 92 | 86 | 88 |
| Syngenta AG | 70 | 84 | 91 | 79 | 74 | 76 | 79 |
| Corteva Agriscience | 67 | 65 | 84 | 71 | 70 | 69 | 71 |
| Mitsui Chemicals Agro Inc. | 66 | 82 | 72 | 64 | 78 | 58 | 70 |
| GreenLight Biosciences | 54 | 59 | 53 | 54 | 73 | 73 | 61 |
| RNAissance Ag | 63 | 49 | 50 | 59 | 55 | 47 | 54 |
| AgroSpheres Inc. | 43 | 62 | 56 | 41 | 54 | 45 | 50 |
| Vestaron Corporation | 57 | 59 | 53 | 48 | 54 | 54 | 54 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Bayer CropScience
- Syngenta AG
- Corteva Agriscience
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Bayer CropScience | ✓ | ✓ | ✓ | ◐ | ✓ | ✓ |
| Syngenta AG | ◐ | ◐ | ✓ | ◐ | ✓ | ◐ |
| Corteva Agriscience | ✓ | − | ✓ | ✓ | ◐ | ✓ |
| Mitsui Chemicals Agro Inc. | ✓ | ✓ | − | − | ◐ | − |
| GreenLight Biosciences | − | ◐ | − | − | ◐ | ✓ |
| RNAissance Ag | ✓ | ◐ | − | − | ◐ | − |
| AgroSpheres Inc. | − | ◐ | − | − | ◐ | − |
| Vestaron Corporation | − | − | ◐ | − | ◐ | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Bayer CropScience88
2Syngenta AG79
3Corteva Agriscience71
4Mitsui Chemicals Agro Inc.70
5GreenLight Biosciences61
6RNAissance Ag54
7Vestaron Corporation54
8AgroSpheres Inc.50
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Bayer CropScienceSyngenta AG
Challenger2
Strong scale, closing on the leaders.
Corteva AgriscienceMitsui Chemicals Agro Inc.
Contender1
Focused players with pockets of strength.
GreenLight Biosciences
Niche3
Specialists in a single segment or region.
RNAissance AgAgroSpheres Inc.Vestaron Corporation
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Target Pest Type in North America, then scale across RNA Interference-based Biopesticides Market — a $442M beachhead inside a $7.07B market.
Beachhead (SOM)$442Mobtainable near-term
Serviceable (SAM)$2.66Breachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale5 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion91 fit
Insect Pests
Best fit — highest urgency & budget in Target Pest Type.
Economic buyer76 fit
Fungal Pathogens
Strong fit — clear ROI and a fast path to value.
End user65 fit
Nematodes
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Target Pest Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Application Method & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Formulation Type
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales48%
Partner / channel26%
Digital / self-serve20%
Marketplaces6%
Positioning & messaging
§GTM 2 · p.194 →For Target Pest Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win RNA Interference-based Biopesticides Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified43%
Sales qualified23%
Evaluation12%
Closed-won6%
$10.2KCAC
$59KLTV
5.8:1LTV : CAC
< 2 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
RNA Interference-based Biopesticides Market is a durable-growth opportunity — $4.78B by 2033, compounding at 9.2%.
TAM · 2025$2.36Btoday
TAM · 2033$4.78Bforecast
CAGR9.2%2027–2033
Cumulative$31.0Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$4.78BTotal addressable market
SAM$1.87BServiceable available market
SOM$361MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →9.2% CAGR
Demand compounds through 2033, outpacing GDP across Target Pest Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Target Pest Type moving from early to mainstream — durable secular demand.
Consolidation upside
14+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$4.78BLarge & growingTAM by 2033 at 9.2% CAGR
$1.87BServiceable nowreachable with today’s model
$361MBeachhead winobtainable near-term share
14+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$3.73BBear6.0% CAGR
$4.78BBase9.2% CAGR
$6.12BBull12.2% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Application Method optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
RNA Interference-based Biopesticides Market — a $6.93B market by 2033. Plan: grow share from 7.2% to 13.6%.
Market size · 2033$6.93Btotal addressable
Market CAGR3.8%2027–2033
Target share13.6%from 7.2% today
Revenue ambition$942Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 7.2% | 13.6% | At risk |
| Revenue | $489M | $942M | At risk |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | At risk |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | At risk |
| Gross margin | 31.2% | 45.0% | On track |
| Customer retention | 88.1% | 96.7% | At risk |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Target Pest Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Application Method capability
A defensible second engine — invest in Application Method to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Target Pest Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Application Method
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $123M capacity & capability investment
- Greenlight bolt-on M&A in Application Method
- Authorise North America expansion plan
- Fund R&D program for Target Pest Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownBehind
- Competitive share lossAt risk
- Input-cost & supply riskAhead
- Regulatory / policy changeBehind
- Execution & talentBehind
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the RNA Interference-based Biopesticides Market conversation — a $4.47B market you can size, segment and defend in minutes.
Market size · 2033$4.47Btotal opportunity
Growth6.4%CAGR to 2033
Addressable buyers1,043+accounts in scope
Typical ROI5×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Target Pest Type
Goal Grow share in Target Pest Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →5×return on cost, year one
< 2 mopayback period
$86K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
14+players profiled in this market
Coverage includes
Bayer CropScienceSyngenta AGCorteva AgriscienceMitsui Chemicals Agro Inc.GreenLight BiosciencesRNAissance AgAgroSpheres Inc.Vestaron Corporation+6 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your RNA Interference-based Biopesticides Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
RNA Interference-based Biopesticides Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Agriculture · scroll →RNAi Biopesticides Market
Market size, share, segmentation and regional forecast.
$4.0B market · 2025 base year
View reportRNA Interference Biopesticides Market
Market size, share, segmentation and regional forecast.
$3.3B market · 2025 base year
View reportIrrigation Dripline Market
Market size, share, segmentation and regional forecast.
$6.0B market · 2025 base year
View reportAutonomous Rice Transplanter Market
Market size, share, segmentation and regional forecast.
$1.3B market · 2025 base year
View reportPlant-Based Organic Fertilizers Market
Market size, share, segmentation and regional forecast.
$4.1B market · 2025 base year
View reportHydroponics Fertilizer Additive Market
Market size, share, segmentation and regional forecast.
$4.2B market · 2025 base year
View reportFeed Salt Bricks Market
Market size, share, segmentation and regional forecast.
$3.5B market · 2025 base year
View reportFeed Grade Shrimp Meal Market
Market size, share, segmentation and regional forecast.
$4.6B market · 2025 base year
View reportIndoor Potted Plants Market
Market size, share, segmentation and regional forecast.
$5.1B market · 2025 base year
View reportSecondary Micronutrients Fertilizer Market
Market size, share, segmentation and regional forecast.
$1.5B market · 2025 base year
View reportSlow-release Liquid Nitrogen Fertilizer Market
Market size, share, segmentation and regional forecast.
$3.7B market · 2025 base year
View reportSlow Release Liquid Fertiliser Market
Market size, share, segmentation and regional forecast.
$2.0B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.